Medical Ventures Corp. Company Profile

11:26 EDT 20th March 2018 | BioPortfolio

Medical Ventures Corp. (“MEV”) develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a clinical need in the cardiovascular marketplace. Our strategy is to acquire and develop technologies and products that are within two years of commercialization and to increase the value of our technologies through the commercialization process.


13700 Mayfield Place, Suite 2135
British Columbia
V6V 2E4


Phone: 604-270-4344
Fax: 604-270-4384

News Articles [519 Associated News Articles listed on BioPortfolio]

Progressive Care Engages Mass Ventures Corp for Digital and Technology Solutions

MIAMI, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that it has engaged Mass Ventures Corp, a Florida company, to ...

Collective Medical Raises $47.5M to Expand Care Team Collaboration Network

Collective Medical, a Utah-based network for care collaboration has raised $47 million in Series A funding led by Kleiner Perkins with participation from Bessemer Venture Partners, Maverick Ventures, ...

Eko raises $5mm in Series A round

Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic Partners, Dreamlt Ventures, 1812 Ventures, and

Eko raises $5M Series A to add staff, support clinical studies for digital stethoscope

ARTIS Ventures led the Series A round. Other investors that took part included Strategic Partners, Dreamlt Ventures, 1812 Ventures, and

Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic

The round was led by New Enterprise Associates and joined by Sofinnova Ventures and Vida Ventures, as well as existing investors OrbiMed, SV Health Investors, Osage University Partners, and Mission Ba...

New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures

The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures.

Abbvie, Pfizer Jump in on Newly-Launched Jnana Therapeutics' $50M Funding Round

Seed funders Polaris Partners and Avalon Ventures were joined in the Series A syndicate by Versant Ventures, AbbVie Ventures, and Pfizer R&D Innovate.

HealthiPASS Raises $7.2M for Patient-Centric Digital Payments Platform

HealthiPASS,  a Chicago-based healthcare payments company, today announced it has raised a $7.2 million in Series A funding round, led by FCA Venture Partners. The round also included participation ...

PubMed Articles [1730 Associated PubMed Articles listed on BioPortfolio]

Tiny Conveyance: Micro- and Nanorobots Prepare to Advance Medicine.

In the science-fiction classic Fantastic Voyage [1], a shrink-ray zaps a submarine and the crew within it, and the resulting microscopic vehicle ventures inside a human body to destroy a blood clot an...

Evaluating Resident Perspectives on International Humanitarian Missions.

Opportunities for international missions are highly sought after by medical students, residents, and attending plastic surgeons. The educational benefits and ethical considerations of trainees partici...

The MD-MEd Joint-Degree Program at Vanderbilt University: Training Future Expert Medical Educators.

Some medical students are drawn to medical education as an area of academic specialization. However, few options exist for medical students who wish to build a scholarly foundation for future careers ...

Medical specialty preferences in early medical school training in Canada.

To understand what medical students consider when choosing their specialty, prior to significant clinical exposure to develop strategies to provide adequate career counseling.

Physicians-in-training are not prepared to prescribe medical marijuana.

While medical marijuana use is legal in more than half of U.S. states, evidence is limited about the preparation of physicians-in-training to prescribe medical marijuana. We asked whether current medi...

Clinical Trials [1518 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Chart Review Study of Medical Abortion

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal miso...

The Influence of Medical Clowns on the Performance of Pulmonary Function Tests Among Preschooler Children

Medical clowns are known to assist in relaxing children and allowing better cooperation during performance of medical procedures. The ability of medical clowns to improve the motivation o...

Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?

The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women rand...

Companies [1724 Associated Companies listed on BioPortfolio]

Torax Medical, Inc.

Torax Medical, Inc. is a privately held medical device company headquartered in St. Paul, Minnesota that develops and markets products designed to treat sphincter disorders utiliz...

OptiMedica Corp.

OptiMedica Corp. is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Now exclusively ...

CardioPolymers, Inc.

CardioPolymers, Inc., a Delaware Corporation (formerly known as Symphony Medical) was founded in 2003 and is headquartered in Orange County, California. The Company is privately held and backed by ven...

Medical Ventures Corp.

Medical Ventures Corp. (“MEV”) develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a cli...

At Pappas Ventures

Pappas Ventures, our sole focus is investing in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Our success, however, is not simply...

More Information about "Medical Ventures Corp." on BioPortfolio

We have published hundreds of Medical Ventures Corp. news stories on BioPortfolio along with dozens of Medical Ventures Corp. Clinical Trials and PubMed Articles about Medical Ventures Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medical Ventures Corp. Companies in our database. You can also find out about relevant Medical Ventures Corp. Drugs and Medications on this site too.

Quick Search


Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record